global corporate citizenship outcomes of wec sessions with the financial and ngo communities jack s....

9
Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

Upload: spencer-lee

Post on 16-Jan-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

Global Corporate Citizenship

Outcomes of WEC Sessions with the Financial and NGO Communities

Jack S. Kace

Page 2: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

Roche Corporate Principles

MissionOur aim as a leading healthcare company is to create, produce and market innovative solutions of high quality for unmet medical needs. Our products and services help to prevent, diagnose and treat diseases, thus enhancing people’s health and quality of life. We do this in a responsible and ethical manner and with a commitment to sustainable development respecting the needs of the individual, the society and the environment.

Page 3: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

CNS -1 %

Infectious diseases -6 %

Virology +3 %

Other -5 %

Oncology +33 %

Dermatology -13 % Transplantation +17 %Anaemia +79 %

Metabolic disorders -2%

Inflammation/ bone -9 %

Cardiovascular +8 %

Roche Divisions / Pharmaceuticals

Prescription sales 2002 by therapeutic area

Page 4: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

R&D / DiagnosticsLeveraging: Competencies and Resources

Research Field

Professionals

Consumers

Applied Science

MolecularDiagnostics

CentralizedDiagnostics

Near PatientTesting

Diabetes Care

IndustrialBiochemicals

Harmonized systems platforms

LightCycler

ExtensionsProteinExpression

Viral LoadMonitoring

BloodScreening

Menu Extension

Single StripSystem

Integrated Spot

Monitoring

BG/ ElectrolyteExtensions

Continuous Monitoring

Automated Pancreas

Primary Care SystemGenomics / Proteomics New diagnostic markers

PCR Microbiology/Sepsis

Integrated Cancer Care

Micro / Nano Technologies (microarrays /microfluidics)

Informatics

Page 5: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

Roche Key Figures

Sales: 29.7 Billion CHF

R&D: 4.3 Billion CHF

Employees: 69,700

Europe 47%

North America 26%

Asia 16%

Latin America 8%

Other 3%

More Information at www.Roche.com

Page 6: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

Roche EH&S Key Figures

11th Year of EH&S Public Reporting (Since 1992)

5th Year of Third Party Verification of Report by PWC

Eco-Efficiency Indicators (compared to sales)

1992 - 2001

Energy Usage - 46.5%

CO2 emissions -60.5%

VOC emissions -79.6%

Chemical Wastes - 65.0%

Page 7: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

WEC CSR Indicator Screen

• Brings together many Sustainable Development Charters

• Allows weighting of Indicators based on importance to company and stakeholder

• Our dilemma - how to rank the importance to our stakeholders

Page 8: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

Key Issues for Financial & NGO Communities

• Selection of similar indicators

• Database for comparing results

• Clear Definitions

• Third Party Verification

Page 9: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace

Corporate Citizenship Measures Should be

• Well Defined

• Consistent

• Audited / Verified